Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Nano-Hybrid Delivery System for Sequential Utilization of Passive and Active Targeting

a delivery system and hybrid technology, applied in the direction of nanocapsules, pharmaceutical delivery mechanisms, capsule delivery, etc., can solve the problems of preventing the clinical translation of polycations in drug delivery

Active Publication Date: 2013-05-16
THE BOARD OF TRUSTEES OF THE UNIV OF ILLINOIS
View PDF1 Cites 28 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention is a nanohybrid drug delivery composition composed of a multivalent polymeric scaffold with a therapeutic agent and targeting agent attached thereto; and a shell encapsulating the polymeric scaffold. The shell can be made of a phospholipid or a polymer, which can be modified to improve its properties. The therapeutic agent can be an anti-cancer agent, anti-angiogenic agent, or anti-viral agent, which can be targeted to a cancer cell or immune cell. The nanohybrid drug delivery composition can be used to prevent or treat diseases or conditions.

Problems solved by technology

However, toxicity issues related to the strong cationic surface charge have hindered clinical translation of the polycations in drug delivery, largely due to the lack of kinetic control over non-specific electrostatic interactions with blood components and rapid clearance by the reticuloendothelial system (RES) (Oupicky, et al.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nano-Hybrid Delivery System for Sequential Utilization of Passive and Active Targeting
  • Nano-Hybrid Delivery System for Sequential Utilization of Passive and Active Targeting
  • Nano-Hybrid Delivery System for Sequential Utilization of Passive and Active Targeting

Examples

Experimental program
Comparison scheme
Effect test

example 1

Materials and Methods

[0054]Materials.

[0055]Branched PEI (Mn 10,000), PLGA (50:50, Mw 40,000-75,000), poly(vinyl alcohol) (PVA, 87-89% hydrolyzed, Mw 13,000-23,000), rhodamine B isothiocyanate (RITC, mixed isomers), dichloromethane (DCM), pyridine, p-nitrophenyl chloroformate (p-NPC), triethyleamine (TEA), diethyl ether, and cholesterol were all obtained from Sigma-Aldrich (St. Louis, Mo.). Amine-terminated methoxy PEG (mPEG-NH2) (Mw 5,000) was obtained from Nektar (Huntsville, Ala.). 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-mPEG-2000 (DSPE-PEG 2000), 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC), and 1,2-dioleoyl-sn-glycero-3-phospho-(1′-rac-glycerol) sodium salt (DOPG) were purchased from Avanti Polar Lipids Inc. (Alabaster, Ala.). All other chemicals used in this study were purchased from Sigma-Aldrich unless specified otherwise.

[0056]Preparation and Characterization of PEI-RITC Conjugates.

[0057]PEI was fluorescently labeled by conjugation with RITC using a similar me...

example 2

Preparation and Characterization of PEI-RITC Conjugates and PEG-PLGA Copolymer

[0082]The UV / Vis measurements revealed the number of RITC molecules attached to a PEI chain. By constructing a calibration curve of UV absorbance of RITC against various concentrations at 555 nm (λmax) the RITC concentration in a solution of the PEI-RITC conjugate was calculated from the absorbance at 555 nm. The molar ratio of PEI and RITC was then calculated by converting the concentration values to number of moles. The results indicated the presence of 6.2 RITC molecules per PEI chain. Particle size and zeta potential of the conjugates were measured to be 11.2 nm and 32.1 mV, respectively (Table 1). In addition, the chemical structure of PEG-PLGA was confirmed by 1H NMR. On the basis of the relative integration values of the characteristic peaks of each polymer, the ratio of the PEG block to the PLGA block was measured to be 1.3:1-2.4:1.

TABLE 1LoadingZeta(μg / mgLoadingParticlePotentialpolymerEfficiencyFo...

example 3

Preparation and Characterization of PEI-RITC-Encapsulated Nanohybrids

[0083]It is highly desirable for a potential tumor-targeted delivery system to possess a size range of less than 200 nm in order to be able to passively accumulate into the tumor tissue. The size of the liposome-based system was controlled by extrusion using a membrane filter with pore size of 100 nm according to a slightly modified method previously described (Ko, et al. (2009) supra). For encapsulation into the polymeric NPs, the double emulsion method was chosen as it enables encapsulation of hydrophilic materials into a variety of polymers or copolymers with a controlled particle size (Perez, et al. (2001) supra; Vauthier & Bouchemal (2009) Pharm. Res. 26:1025-1058). As shown in Table 1, the encapsulation methods employed herein were successful in controlling the size, as particle sizes for all three nanohybrids were in the range of 100-150 nm. Both methods also showed relatively good loading efficiencies (45-9...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Compositionaaaaaaaaaa
Electrical resistanceaaaaaaaaaa
Solubility (mass)aaaaaaaaaa
Login to View More

Abstract

The present invention features nanohybrid drug delivery composition which combines both passive and active targeting for the prevention and treatment of disease. The composition is shell-encapsulated multivalent polymeric scaffold with a therapeutic agent and targeting agent attached thereto.

Description

[0001]This application is claims benefit of priority to U.S. Provisional Application Ser. No. 61 / 327,200, filed Apr. 23, 2010, the content of which is incorporated herein by reference in its entirety.BACKGROUND OF THE INVENTION[0002]Multifunctional macromolecules have demonstrated great potential as drug delivery vectors (Nori & Kopecek (2005) Adv. Drug Deliv. Rev. 57:609-636; Patri, et al. (2002) Curr. Opin. Chem. Biol. 6:466-471). In particular, polycationic polymers have been widely explored for many biomedical applications, including gene delivery (Verma & Somia (1997) Nature 389:239-242). One of the most commonly used cationic polymers is polyethylenimine (PEI) that has been primarily used as a nonviral gene delivery vector given its capacity to protect DNA from lysosomal degradation and promote endosomal escape (Boussif, et al. (1995) Proc. Natl. Acad. Sci. USA 92:7297-7301; Gebhart & Kabanov (2001) J. Control. Release 73:401-416; Akinc, et al. (2005) J. Gene Med. 7:657-663; U...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/127A61K9/14
CPCA61K9/1273A61K9/14A61K9/127A61K9/5153A61K9/146
Inventor HONG, SEUNGPYOLIU, YING
Owner THE BOARD OF TRUSTEES OF THE UNIV OF ILLINOIS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com